eResearch Technology, Incorporated (ERES)
Email Confirmation
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
Dr. Michael J. McKelvey, Ph.D., CEO/President/Director
30 South 17th Street
Philadelphia, PA 19103
US
Map it ![]()
Overview
The Company provides technology and services that enable the pharmaceutical, biotechnology and medical device industries to collect, interpret and distribute cardiac safety and clinical data more efficiently.
Press Releases
-
eResearchTechnology, Inc. to Announce 2008 Third Quarter Results on October 30, 2008 Oct-09-2008, 09:35AM EDT
-
SectorWatch.biz Issues MarketStats on NWCI, ERES, STJ, MDT, BSX, and CSCX Oct-01-2008, 06:30AM EDT
Employees
Number of Employees: 339
Revenue per Employee: $276,043
Top Executives
Robert S. Brown, Senior VP, Divisional
Dr. Joel Morganroth, M.D., Chairman of the Board/Chief Scientific Officer/Director
Thomas P. Devine, Executive VP/Other Executive Officer
Keith D. Schneck, Executive VP/CFO/Secretary
David Laky, Senior VP, Divisional
Amy Furlong, Executive VP, Divisional
Gregory Sadowski, Senior VP, Divisional
Dr. Jeffrey S. Litwin, M.D., Executive VP/Chief Medical Officer
George Tiger, Senior VP, Divisional
Board of Directors
Dr. Joel Morganroth, M.D., Chairman of the Board/Chief Scientific Officer/Director
Stephen M. Scheppmann, Director
Keith D. Schneck, Executive VP/CFO/Secretary
Steven M. Eisenstein, Vice President/Secretary
Michael DeMane, Director
Stephen S. Phillips, Director
Financials
Quarterly
Annual
| Income Statement | 08/2008 | 05/2008 | 02/2008 | 11/2007 |
|---|---|---|---|---|
| Sales | 11.02 Mil. | 11.64 Mil. | 9.64 Mil. | 8.54 Mil. |
| Gross Operating Profit | 24.45 Mil. | 22.04 Mil. | 19.27 Mil. | 15.43 Mil. |
| Operating Income before D & A (EBITDA) | 14.99 Mil. | 12.84 Mil. | 11.61 Mil. | 9.29 Mil. |
| Total Income Before Interest Expenses (EBIT) | 11 Mil. | 8.92 Mil. | 8.05 Mil. | 5.94 Mil. |
| Total Net Income | 6.66 Mil. | 5.75 Mil. | 5.16 Mil. | 3.71 Mil. |
| Basic EPS, Total | 0.13 | 0.11 | 0.1 | 0.07 |
| Diluted EPS, Total | 0.13 | 0.11 | 0.1 | 0.07 |
| BALANCE STATEMENT | 08/2008 | 05/2008 | 02/2008 | 11/2007 |
|---|---|---|---|---|
| Cash and Equivalents | 49.45 Mil. | 40.57 Mil. | 38.08 Mil. | 27.2 Mil. |
| Total Assets | 90.34 Mil. | 79.92 Mil. | 78.33 Mil. | 97.86 Mil. |
| Total Liabilities | 28.05 Mil. | 26.2 Mil. | 32.96 Mil. | 22.48 Mil. |
| Total Capitalization | 129.2 Mil. | 120.03 Mil. | 113.51 Mil. | 108.01 Mil. |
| Cash Flow | 08/2008 | 05/2008 | 02/2008 | 11/2007 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | 17.98 Mil. | 7.6 Mil. | 36 Mil. | 22.72 Mil. |
| Net Cash From Investing Activities | -7.64 Mil. | -4.65 Mil. | -13.33 Mil. | -11.56 Mil. |
| Net Cash From Financing Activities | 1.02 Mil. | -459 K. | -89 K. | 266 K. |
| Net Change in Cash & Cash Equivalents | 11.36 Mil. | 2.49 Mil. | 22.58 Mil. | 11.7 Mil. |
| Income Statement | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Sales | 33.5 Mil. | 33.28 Mil. | 28 Mil. | 27.57 Mil. |
| Gross Operating Profit | 65.19 Mil. | 53.08 Mil. | 58.85 Mil. | 81.82 Mil. |
| Operating Income before D & A (EBITDA) | 37.38 Mil. | 23.22 Mil. | 34.18 Mil. | 58.24 Mil. |
| Total Income Before Interest Expenses (EBIT) | 24.46 Mil. | 13.22 Mil. | 24.37 Mil. | 50.22 Mil. |
| Total Net Income | 15.25 Mil. | 8.31 Mil. | 15.36 Mil. | 29.72 Mil. |
| Basic EPS, Total | 0.3 | 0.17 | 0.31 | 0.58 |
| Diluted EPS, Total | 0.29 | 0.16 | 0.29 | 0.54 |
| BALANCE STATEMENT | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Cash and Equivalents | 38.08 Mil. | 15.5 Mil. | 18.43 Mil. | 45.81 Mil. |
| Total Assets | 78.33 Mil. | 81.27 Mil. | 70.55 Mil. | 87.39 Mil. |
| Total Liabilities | 32.96 Mil. | 19.95 Mil. | 24.75 Mil. | 29.48 Mil. |
| Total Capitalization | 113.51 Mil. | 93.62 Mil. | 79.97 Mil. | 86.85 Mil. |
| Cash Flow | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | 36 Mil. | 16.33 Mil. | 26.19 Mil. | 59.62 Mil. |
| Net Cash From Investing Activities | -13.33 Mil. | -20.95 Mil. | -29.78 Mil. | -26.74 Mil. |
| Net Cash From Financing Activities | -89 K. | 1.3 Mil. | -23.57 Mil. | -25.58 Mil. |
| Net Change in Cash & Cash Equivalents | 22.58 Mil. | -2.94 Mil. | -27.37 Mil. | 7.44 Mil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
517.32 Mil.
545.94 Mil.
372.48 Mil.
364.99 Mil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- To request a change please click here
Also in Portfolio.com
Most Read
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.





